Hair Dye Use, Genetic Variation in N-acetyltransferase 1 (Nat1) and 2 (Nat2), and Risk of Non-hodgkin Lymphoma.
From: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD 20852, USA. mortonli@mail.nih.gov
Carcinogenesis
- Publish Date: Aug 2007
- ISSN: 0143-3334
- Volume: 28
- Issue: 8
- Pages: 1759-64
- Medium: Print
- Language: English
- Citation (JAMA): Morton Lindsay M, Bernstein Leslie, Wang Sophia S, et al. Hair Dye Use, Genetic Variation in N-acetyltransferase 1 (Nat1) and 2 (Nat2), and Risk of Non-hodgkin Lymphoma.. Carcinogenesis Aug 2007;28:1759-64
Abstract
BACKGROUND: Several previous studies have found non-Hodgkin lymphoma (NHL) risk to be associated with hair dye use, particularly use of permanent, dark colors and use before 1980, when hair dye formulations changed. METHODS: We examined NHL risk in relation to reported hair dye use among 1,321 cases and 1,057 controls from a US population-based multi-center study. DNA was extracted from blood or buccal cells to identify genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), which encode enzymes that metabolize aromatic amine compounds found in hair dyes. RESULTS: Among women, 509 cases and 413 controls reported hair dye use [odds ratio (OR) = 1.2; 95% confidence interval (95% CI) = 0.9, 1.6]. Risk estimates were higher for use before 1980 than for use in 1980 or later, particularly for use of permanent, intense tone (black, dark brown, dark blonde) products (<1980-OR = 1.6; 95% CI 0.9, 2.7; >or=1980-OR = 0.6; 95% CI 0.4, 1.1). Risk estimates were increased for women who used permanent, intense tone products before 1980 if they had the rapid/intermediate NAT2 phenotype (OR = 3.3; 95% CI 1.3, 8.6) or the NAT1 10 allele (OR = 2.5; 95% CI 0.9, 7.6), but not if they were slow NAT2 acetylators (OR = 1.5; 95% CI 0.6, 3.6) or had no copies of the NAT1 10 allele (OR = 1.5; 95% CI 0.7, 3.3). NHL risk was not increased among women who began hair dye use after 1980 or among men. CONCLUSION: Our results support previous research demonstrating elevated NHL risk among women who used dark color or intense tone permanent hair dyes before 1980. We present the first evidence suggesting that this risk may differ by genetic variation in NAT1 and NAT2.
Mesh Headings (Keywords): Adult, Aged, Arylamine N-Acetyltransferase, Case-Control Studies, Female, Genetic Predisposition to Disease, Hair Dyes, Humans, Isoenzymes, Lymphoma, Non-Hodgkin, Male, Middle Aged, Risk Factors, Variation (Genetics)
Check for Full Text / PubMed Unique Identifier (PMID): 17522066
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.
